Transient	transient	O	O	OTHERS	I
neurologic	neurologic	O	O	OTHERS	I
symptoms	symptoms	O	O	OTHERS	I
after	after	O	O	O	O
spinal	spinal	O	O	O	O
anesthesia	anesthesia	O	O	O	O
:	:	O	O	O	O
a	a	O	O	O	O
lower	lower	O	O	O	O
incidence	incidence	O	O	O	O
with	with	O	O	O	O
prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
than	than	O	O	O	O
with	with	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Recent	recent	O	O	O	O
evidence	evidence	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
transient	transient	O	O	OTHERS	I
neurologic	neurologic	O	O	OTHERS	I
symptoms	symptoms	O	O	OTHERS	I
(	(	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
)	)	O	O	O	O
frequently	frequently	O	O	O	O
follow	follow	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
spinal	spinal	O	O	O	O
anesthesia	anesthesia	O	O	O	O
but	but	O	O	O	O
are	are	O	O	O	O
infrequent	infrequent	O	O	O	O
with	with	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
identification	identification	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
short-acting	short-acting	O	O	O	O
local	local	O	O	O	O
anesthetic	anesthetic	O	O	O	O
to	to	O	O	O	O
substitute	substitute	O	O	O	O
for	for	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
brief	brief	O	O	O	O
surgical	surgical	O	O	O	O
procedures	procedures	O	O	O	O
remains	remains	O	O	O	O
an	an	O	O	O	O
important	important	O	O	O	O
goal	goal	O	O	O	O
.	.	O	O	O	O

Prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
an	an	O	O	O	O
amide	amide	O	O	O	O
local	local	O	O	O	O
anesthetic	anesthetic	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
action	action	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Accordingly	accordingly	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
,	,	O	O	O	O
prospective	prospective	O	O	O	O
double-blind	double-blind	O	O	O	O
study	study	O	O	O	O
compares	compares	O	O	O	O
prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
respect	respect	O	O	O	O
to	to	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
action	action	O	O	O	O
and	and	O	O	O	O
relative	relative	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Ninety	ninety	O	O	O	O
patients	patients	O	O	O	O
classified	classified	O	O	O	O
as	as	O	O	O	O
American	american	O	O	O	O
Society	society	O	O	O	O
of	of	O	O	O	O
Anesthesiologists	anesthesiologists	O	O	O	O
physical	physical	O	O	O	O
status	status	O	O	O	O
I	i	O	O	O	O
or	or	O	O	O	O
II	ii	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
scheduled	scheduled	O	O	O	O
for	for	O	O	O	O
short	short	O	O	O	O
gynecologic	gynecologic	O	O	O	O
procedures	procedures	O	O	O	O
under	under	O	O	O	O
spinal	spinal	O	O	O	O
anesthesia	anesthesia	O	O	O	O
were	were	O	O	O	O
randomly	randomly	O	O	O	O
allocated	allocated	O	O	O	O
to	to	O	O	O	O
receive	receive	O	O	O	O
2.5	2.5	O	O	O	O
ml	ml	O	O	O	O
2	2	O	O	O	O
%	%	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
7.5	7.5	O	O	O	O
%	%	O	O	O	O
glucose	glucose	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
2	2	O	O	O	O
%	%	O	O	O	O
prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
7.5	7.5	O	O	O	O
%	%	O	O	O	O
glucose	glucose	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
0.5	0.5	O	O	O	O
%	%	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
7.5	7.5	O	O	O	O
%	%	O	O	O	O
glucose	glucose	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
solutions	solutions	O	O	O	O
were	were	O	O	O	O
provided	provided	O	O	O	O
in	in	O	O	O	O
blinded	blinded	O	O	O	O
vials	vials	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
hospital	hospital	O	O	O	O
pharmacy	pharmacy	O	O	O	O
.	.	O	O	O	O

Details	details	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	O	O	O
puncture	puncture	O	O	O	O
,	,	O	O	O	O
extension	extension	O	O	O	O
and	and	O	O	O	O
regression	regression	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	O	O	O
block	block	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
times	times	O	O	O	O
to	to	O	O	O	O
reach	reach	O	O	O	O
discharge	discharge	O	O	O	O
criteria	criteria	O	O	O	O
were	were	O	O	O	O
noted	noted	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
evening	evening	O	O	O	O
of	of	O	O	O	O
postoperative	postoperative	O	O	O	O
day	day	O	O	O	O
1	1	O	O	O	O
,	,	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
evaluated	evaluated	O	O	O	O
for	for	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
by	by	O	O	O	O
a	a	O	O	O	O
physician	physician	O	O	O	O
unaware	unaware	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
administered	administered	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
details	details	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
anesthetic	anesthetic	O	O	O	O
procedure	procedure	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Nine	nine	O	O	O	O
of	of	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
experienced	experienced	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
,	,	O	O	O	O
1	1	O	O	O	O
of	of	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
0.03	0.03	O	O	O	O
)	)	O	O	O	O
had	had	O	O	O	O
them	them	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
none	none	O	O	O	O
of	of	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
had	had	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Times	times	O	O	O	O
to	to	O	O	O	O
ambulate	ambulate	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
void	void	O	O	O	O
were	were	O	O	O	O
similar	similar	O	O	O	O
after	after	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
150	150	O	O	O	O
vs.	vs.	O	O	O	O
165	165	O	O	O	O
min	min	O	O	O	O
and	and	O	O	O	O
238	238	O	O	O	O
vs.	vs.	O	O	O	O
253	253	O	O	O	O
min	min	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
but	but	O	O	O	O
prolonged	prolonged	O	O	O	O
after	after	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
200	200	O	O	O	O
and	and	O	O	O	O
299	299	O	O	O	O
min	min	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Prilocaine	prilocaine	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
preferable	preferable	O	O	O	O
to	to	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
short	short	O	O	O	O
surgical	surgical	O	O	O	O
procedures	procedures	O	O	O	O
because	because	O	O	O	O
it	it	O	O	O	O
has	has	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
action	action	O	O	O	O
but	but	O	O	O	O
a	a	O	O	O	O
lower	lower	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
TNSs	tnss	O	DISEASE	OTHERS	I
.	.	O	O	O	O

